[Relation between prognosis and the Su-PS skin reaction in patients with non-resected primary lung cancer receiving OK-432]
- PMID: 2823723
[Relation between prognosis and the Su-PS skin reaction in patients with non-resected primary lung cancer receiving OK-432]
Abstract
Chemotherapy and administration of OK-432 were performed concomitantly in 49 cases of inoperable primary lung cancer, and the Su-PS skin reaction was measured. In the group of patients under 60 years of age, the maximum diameter of the reaction after chemotherapy tended to be large, and evaluation of the results showed that the maximum diameter tended to be large in the group showing tumor contraction effects. In a comparison of the prognosis between the group which survived for less than 6 months and that which survived for 6 months or longer, there was no significant difference between them before administration of OK-432, but when the maximum reaction diameter after chemotherapy was compared, that in the group which survived for 6 months or longer was significantly stronger (p less than 0.05). The Su-PS skin reaction at the time of administration of OK-432 is therefore considered to be a useful immunological parameter for predicting the results of treatment and also for prognosis.
Similar articles
-
[Role of immune skin reactions in progressive lung cancer during the administration of OK-432--relation to reactions to DNCB, PPD and Su-PS].Gan To Kagaku Ryoho. 1987 Jan;14(1):61-70. Gan To Kagaku Ryoho. 1987. PMID: 3026256 Japanese.
-
[Clinical significance of Su-polysaccharide (Su-PS) skin test in patients with primary lung cancer treated with chemotherapy and administration of OK-432, with special reference to the therapeutic effect and prognosis].Gan To Kagaku Ryoho. 1990 Mar;17(3 Pt 2):468-74. Gan To Kagaku Ryoho. 1990. PMID: 2181937 Japanese.
-
[The Su-polysaccharide skin test in lung cancer].Gan To Kagaku Ryoho. 1987 Sep;14(9):2697-702. Gan To Kagaku Ryoho. 1987. PMID: 3307634 Japanese.
-
[Surgery and adjuvant therapy of non-small cell lung cancer].Gan To Kagaku Ryoho. 1986 Apr;13(4 Pt 2):1534-46. Gan To Kagaku Ryoho. 1986. PMID: 3524465 Review. Japanese.
-
[Clinicopathological study on primary lung cancer--immunohistochemical expression of p53 suppressor gene and bcl-2 oncogene in relation to prognosis].Rinsho Byori. 1996 Jan;44(1):32-41. Rinsho Byori. 1996. PMID: 8691638 Review. Japanese.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical